05/01/2024
We are thrilled to announce the 7th peer-reviewed publication from Monteris Medical's own LAANTERN prospective multicenter study, documenting the largest cohort to date of LITT for meningioma, the most common primary brain tumor. The LAANTERN study has concluded with more than 1,000 patients enrolled! We look forward to the investigators publishing real world outcomes for this expansive population undergoing NeuroBlate. Read more: https://www.monteris.com/press-releases/monteris-medical-announces-publication-of-largest-cohort-to-date-of-litt-with-neuroblate-system-for-meningioma-most-common-primary-brain-tumor/